Human CD63/LAMP-3/ME491 ORF/cDNA clone-Adeno-associate virus(AAV) particle (NM_001780.5)
Cat. No.: vGMAAV000550
Pre-made Human CD63/LAMP-3/ME491 Adeno-associated virus particle for CD63 in-vivo study, mechanism of action (MOA) research and CD63-associated gene therapy development.
At GM Vector Core (GMVC), we stand at the forefront of custom AAV development and produce distinct grades of AAVs employing state-of-the-art methodologies. Uncover more about our expertise.
Go to
CD63/LAMP/CD63/LAMP-3 products
collection>>
(antibodies,
antigen, VLP, mRNA, ORF viral vector, etc)
Product information
| Catalog No. | Product Name | AAV serotype | AAV Grade | AAV quantity |
| vGMAAV000550 | Human CD63 Adeno-associate virus(AAV) particle | AAV1, AAV2, AAV2 variant (Y444F), AAV2 variant (Y272F, Y444F, Y500F, Y730F), AAV2 variant (Y444F, Y730F, Y500F, Y272F, Y704F, Y252F), AAV2 variant(AAV2.7m8), AAV5, AAV6, AAV8, AAV8-1m, AAV8-2m, AAV8 variant (Y733F, Y447F, Y275), AAV9, AAV-Rh.10, AAV-DJ, AAV-DJ/8, AAV-Retro (Retrograde), AAV9-PHP.B, AAV9-PHP.eB, AAV9-PHP.S, AAV-BR1, AAV-2i8, AAV-SIG, AAV-VEC, AAV4, AAV6.2, AAV6.2FF | Pilot Grade | 1.0E+12VG/ml |
| 5.0E+12VG/ml | ||||
| 1E+13VG/ml | ||||
| 5E+13VG/ml | ||||
| 1E+14VG/ml | ||||
| Research Grade | 1.0E+12VG/ml | |||
| 5.0E+12VG/ml | ||||
| 1E+13VG/ml | ||||
| 5E+13VG/ml | ||||
| 1E+14VG/ml | ||||
| GMP-like Grade | inquiry | |||
| GMP Grade | inquiry |
Product Description
| Catalog ID | vGMAAV000550 |
| Gene Name | CD63 |
| Accession Number | NM_001780.5 |
| Gene ID | 967 |
| Species | Human |
| Product Type | Adeno-associate virus(AAV) particle (overexpression) |
| Insert Length | 717 bp |
| Gene Alias | LAMP-3,ME491,MLA1,OMA81H,TSPAN30 |
| Fluorescent Reporter | mCherry |
| Mammalian Cell Selection | Null |
| Fusion Tag | Null |
| Promoter | CAG |
| Resistance | Amplicin |
| ORF Nucleotide Sequence | ATGGCGGTGGAAGGAGGAATGAAATGTGTGAAGTTCTTGCTCTACGTCCTCCTGCTGGCCTTTTGCGCCTGTGCAGTGGGACTGATTGCCGTGGGTGTCGGGGCACAGCTTGTCCTGAGTCAGACCATAATCCAGGGGGCTACCCCTGGCTCTCTGTTGCCAGTGGTCATCATCGCAGTGGGTGTCTTCCTCTTCCTGGTGGCTTTTGTGGGCTGCTGCGGGGCCTGCAAGGAGAACTATTGTCTTATGATCACGTTTGCCATCTTTCTGTCTCTTATCATGTTGGTGGAGGTGGCCGCAGCCATTGCTGGCTATGTGTTTAGAGATAAGGTGATGTCAGAGTTTAATAACAACTTCCGGCAGCAGATGGAGAATTACCCGAAAAACAACCACACTGCTTCGATCCTGGACAGGATGCAGGCAGATTTTAAGTGCTGTGGGGCTGCTAACTACACAGATTGGGAGAAAATCCCTTCCATGTCGAAGAACCGAGTCCCCGACTCCTGCTGCATTAATGTTACTGTGGGCTGTGGGATTAATTTCAACGAGAAGGCGATCCATAAGGAGGGCTGTGTGGAGAAGATTGGGGGCTGGCTGAGGAAAAATGTGCTGGTGGTAGCTGCAGCAGCCCTTGGAATTGCTTTTGTCGAGGTTTTGGGAATTGTCTTTGCCTGCTGCCTCGTGAAGAGTATCAGAAGTGGCTACGAGGTGATGTAG |
| ORF Protein Sequence | MAVEGGMKCVKFLLYVLLLAFCACAVGLIAVGVGAQLVLSQTIIQGATPGSLLPVVIIAVGVFLFLVAFVGCCGACKENYCLMITFAIFLSLIMLVEVAAAIAGYVFRDKVMSEFNNNFRQQMENYPKNNHTASILDRMQADFKCCGAANYTDWEKIPSMSKNRVPDSCCINVTVGCGINFNEKAIHKEGCVEKIGGWLRKNVLVVAAAALGIAFVEVLGIVFACCLVKSIRSGYEVM |
Reference
Data / case study
Click to get more Data / Case study about the product.
Associated products
Target information
| Target ID | GM-IO085 |
| Target Name | CD63/LAMP |
|
Gene Group Identifier (Target Gene ID in Homo species) |
967 |
| Gene ID |
100051450 (Equus caballus), 12512 (Mus musculus), 29186 (Rattus norvegicus), 404156 (Bos taurus) 474391 (Canis lupus familiaris), 493846 (Felis catus), 709828 (Macaca mulatta), 967 (Homo sapiens) |
| Gene Symbols & Synonyms | CD63,Cd63,ME491,Tspan30,AD1,MLA1,HOP-26,OMA81H,Pltgp40,TSPAN30 |
| Target Alternative Names | AD1,CD63,CD63 antigen,Cd63,Granulophysin,HOP-26,LAMP,Lysosomal-associated membrane protein 3 (LAMP-3),Lysosome integral membrane protein 1 (Limp1),ME491,MLA1,Melanoma-associated antigen ME491,OMA81H,Ocular melanoma-associated antigen,Pltgp40,TSPAN30,Tetraspanin-30 (Tspan-30),Tspan30 |
| Uniprot Accession |
P08962,P28648,P41731,Q76B49,Q9XSK2
Additional SwissProt Accessions: P41731,P28648,Q9XSK2,Q76B49,P08962 |
| Uniprot Entry Name | |
| Protein Sub-location | Transmembrane Protein |
| Category | Therapeutics Target, Immuno-oncology Target |
| Disease | cancer |
| Disease from KEGG | Lysosome, Proteoglycans in cancer |
| Gene Ensembl | ENSECAG00000046524, ENSMUSG00000025351, ENSBTAG00000011931, ENSCAFG00845005463, ENSMMUG00000013232, ENSG00000135404 |
| Target Classification | Checkpoint-Immuno Oncology, Tumor-associated antigen (TAA) |
About GMVC

GMVC (GM Vector Core) is GeneMedi’s unique platform for QbD Viral vectors Processes development and manufacturing. In GMVC, our core expertise lies in the tailored production of viral vectors, including adeno-associated virus (AAV), lentivirus, and adenovirus. Our state-of-the-art facilities are equipped for scalable manufacturing, ensuring high-quality viral vector production to meet both research and therapeutic needs. Our expert team specializes in process development, leveraging innovative technology and extensive industry knowledge to provide clients with tailored solutions that exceed expectations. GMVC will be the ideal partner for scientists and healthcare professionals seeking reliable and efficient viral vector production services.


